Based on these findings, several FAP inhibitors were reported and showed increasing levels of intact FGF21, accompanied by improved insulin resistance and glucose tolerance upon in vivo administration36, thus providing proof of concept of FAP inhibition as a new therapeutic approach. Here, FGF21 is linked to Insulin resistance.